Muhammad Wahab Amjad

1.8k total citations · 1 hit paper
54 papers, 1.4k citations indexed

About

Muhammad Wahab Amjad is a scholar working on Pharmaceutical Science, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Muhammad Wahab Amjad has authored 54 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pharmaceutical Science, 16 papers in Molecular Biology and 13 papers in Organic Chemistry. Recurrent topics in Muhammad Wahab Amjad's work include Advanced Drug Delivery Systems (15 papers), Synthesis and biological activity (12 papers) and Nanoparticle-Based Drug Delivery (11 papers). Muhammad Wahab Amjad is often cited by papers focused on Advanced Drug Delivery Systems (15 papers), Synthesis and biological activity (12 papers) and Nanoparticle-Based Drug Delivery (11 papers). Muhammad Wahab Amjad collaborates with scholars based in Saudi Arabia, Pakistan and Malaysia. Muhammad Wahab Amjad's co-authors include Syed Nasir Abbas Bukhari, Mohd Cairul Iqbal Mohd Amin, Arun K. Iyer, Prashant Kesharwani, Maria Abdul Ghafoor Raja, Zahid Hussain, Ibrahim Jantan, Muhammad Ajaz Hussain, Tarek A. Ahmed and Hnin Ei Thu and has published in prestigious journals such as PLoS ONE, Progress in Polymer Science and Journal of Medicinal Chemistry.

In The Last Decade

Muhammad Wahab Amjad

53 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nanoparticles incorporated hydrogels for delivery of antimicrobial agents: developments and trends

2024 68 citations Naveed Ahmad, Syed Nasir Abbas Bukhari et al. RSC Advances profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Muhammad Wahab Amjad Saudi Arabia	20	439	395	285	244	175	54	1.4k
Xiaoqing Cai China	23	542 1.2×	256 0.6×	303 1.1×	128 0.5×	124 0.7×	61	1.6k
Hriday Bera China	24	289 0.7×	226 0.6×	384 1.3×	241 1.0×	461 2.6×	61	1.5k
Hwa Jeong Lee South Korea	25	1.0k 2.3×	218 0.6×	390 1.4×	115 0.5×	141 0.8×	95	2.1k
Hitesh Kulhari India	25	662 1.5×	412 1.0×	598 2.1×	122 0.5×	298 1.7×	40	2.0k
Abolfazl Barzegar Iran	23	877 2.0×	233 0.6×	228 0.8×	224 0.9×	59 0.3×	83	1.9k
M. Yasmin Begum Saudi Arabia	22	396 0.9×	105 0.3×	286 1.0×	172 0.7×	171 1.0×	102	1.5k
Emiliano Laudadio Italy	22	424 1.0×	148 0.4×	208 0.7×	142 0.6×	48 0.3×	80	1.3k
Divya Dheer India	18	457 1.0×	810 2.1×	219 0.8×	69 0.3×	138 0.8×	26	1.6k
Maryam Iman Iran	17	353 0.8×	332 0.8×	264 0.9×	55 0.2×	99 0.6×	78	1.1k
Abid Naeem China	18	340 0.8×	103 0.3×	247 0.9×	172 0.7×	215 1.2×	62	1.2k

Countries citing papers authored by Muhammad Wahab Amjad

Since Specialization

Citations

This map shows the geographic impact of Muhammad Wahab Amjad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muhammad Wahab Amjad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muhammad Wahab Amjad more than expected).

Fields of papers citing papers by Muhammad Wahab Amjad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muhammad Wahab Amjad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muhammad Wahab Amjad. The network helps show where Muhammad Wahab Amjad may publish in the future.

Co-authorship network of co-authors of Muhammad Wahab Amjad

This figure shows the co-authorship network connecting the top 25 collaborators of Muhammad Wahab Amjad. A scholar is included among the top collaborators of Muhammad Wahab Amjad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muhammad Wahab Amjad. Muhammad Wahab Amjad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ahmad, Naveed, Syed Nasir Abbas Bukhari, Muhammad Ajaz Hussain, et al.. (2024). Nanoparticles incorporated hydrogels for delivery of antimicrobial agents: developments and trends. RSC Advances. 14(19). 13535–13564. 68 indexed citations breakdown →

Wahab, Habibah A., et al.. (2024). Platinum-based targeted chemotherapies and reversal of cisplatin resistance in non-small cell lung cancer (NSCLC). Mutation research. Fundamental and molecular mechanisms of mutagenesis. 828. 111856–111856. 9 indexed citations

Bukhari, Syed Nasir Abbas, et al.. (2023). Covalent Organic Frameworks (COFs) as Multi-Target Multifunctional Frameworks. Polymers. 15(2). 267–267. 44 indexed citations

Amjad, Muhammad Wahab. (2021). DENDRIMERS IN ANTICANCER TARGETED DRUG DELIVERY: ACCOMPLISHMENTS, CHALLENGES AND DIRECTIONS FOR FUTURE. Pharmacy & Pharmacology. 9(1). 4–16. 4 indexed citations

Pandey, Manisha, Hira Choudhury, Rohit Kumar Verma, et al.. (2020). Nanoparticles Based Intranasal Delivery of Drug to Treat Alzheimer’s Disease: A Recent Update. CNS & Neurological Disorders - Drug Targets. 19(9). 648–662. 11 indexed citations

Zaman, Muhammad, et al.. (2020). Solid Lipid Nanoparticles of Mycophenolate Mofetil: An Attempt to Control the Release of an Immunosuppressant. International Journal of Nanomedicine. Volume 15. 5603–5612. 19 indexed citations

Alshehri, Mohammed M., et al.. (2020). Drugs-Inducing Hepatotoxicity. Asian Journal of Pharmaceutical Research and Health Care. 12(3). 148–156. 3 indexed citations

Amjad, Muhammad Wahab & Maria Abdul Ghafoor Raja. (2019). Development and Characterization of Liposome-Enriched Ketoprofen Liposomal Hydrogels. Journal of Pharmaceutical Research International. 1–7.

Mahmood, Asif, Faqir Muhammad, Rai Muhammad Sarfraz, et al.. (2019). Development and in vitro evaluation of (β-cyclodextrin-g-methacrylic acid)/Na+-montmorillonite nanocomposite hydrogels for controlled delivery of lovastatin. International Journal of Nanomedicine. Volume 14. 5397–5413. 23 indexed citations

10.

Qureshi, Sundus Saeed, Muhammad Zaman, Asif Mahmood, et al.. (2019). Development and optimization of flurbiprofen loaded microsponges; an in-vitro evaluation.. PubMed. 32(4(Supplementary)). 1773–1779. 1 indexed citations

11.

Hussain, Zahid, Hnin Ei Thu, Muhammad Wahab Amjad, et al.. (2017). Exploring recent developments to improve antioxidant, anti-inflammatory and antimicrobial efficacy of curcumin: A review of new trends and future perspectives. Materials Science and Engineering C. 77. 1316–1326. 232 indexed citations

12.

Qin, Hua‐Li, Jing Leng, Bahaa G. M. Youssif, et al.. (2017). Synthesis and mechanistic studies of curcumin analog‐based oximes as potential anticancer agents. Chemical Biology & Drug Design. 90(3). 443–449. 43 indexed citations

13.

Zha, Gao‐Feng, Hua‐Li Qin, Bahaa G. M. Youssif, et al.. (2017). Discovery of potential anticancer multi-targeted ligustrazine based cyclohexanone and oxime analogs overcoming the cancer multidrug resistance. European Journal of Medicinal Chemistry. 135. 34–48. 64 indexed citations

14.

Zhang, Cheng‐Pan, Ibrahim Jantan, Muhammad Sher, et al.. (2016). Biological evaluation of synthetic α,β-unsaturated carbonyl based cyclohexanone derivatives as neuroprotective novel inhibitors of acetylcholinesterase, butyrylcholinesterase and amyloid-β aggregation. Bioorganic & Medicinal Chemistry. 24(10). 2352–2359. 31 indexed citations

15.

Amin, Mohd Cairul Iqbal Mohd, Haliza Katas, Muhammad Wahab Amjad, et al.. (2016). pH-Responsive Triblock Copolymeric Micelles Decorated with a Cell-Penetrating Peptide Provide Efficient Doxorubicin Delivery. Nanoscale Research Letters. 11(1). 539–539. 24 indexed citations

16.

Leng, Jing, Hua‐Li Qin, Ibrahim Jantan, et al.. (2016). Evaluation of multifunctional synthetic tetralone derivatives for treatment of Alzheimer's disease. Chemical Biology & Drug Design. 88(6). 889–898. 24 indexed citations

17.

Amjad, Muhammad Wahab, et al.. (2014). Nanoscale Diblock Copolymer Micelles: Characterizations and Estimation of the Effective Diffusion Coefficients of Biomolecules Release through Cylindrical Diffusion Model. PLoS ONE. 9(8). e105234–e105234. 12 indexed citations

18.

Bukhari, Syed Nasir Abbas, Ibrahim Jantan, Vijay H. Masand, et al.. (2014). Synthesis of α, β-unsaturated carbonyl based compounds as acetylcholinesterase and butyrylcholinesterase inhibitors: Characterization, molecular modeling, QSAR studies and effect against amyloid β-induced cytotoxicity. European Journal of Medicinal Chemistry. 83. 355–365. 42 indexed citations

19.

Bukhari, Syed Nasir Abbas, Ibrahim Jantan, Malina Jasamai, Waqas Ahmad, & Muhammad Wahab Amjad. (2013). Synthesis and Biological Evaluation of Curcumin Analogues. Journal of Medical Sciences(Faisalabad). 13(7). 501–513. 15 indexed citations

20.

Bukhari, Syed Nasir Abbas, Adeel Masood Butt, Muhammad Wahab Amjad, et al.. (2013). Synthesis and Evaluation of Chalcone Analogues Based Pyrimidines as Angiotensin Converting Enzyme Inhibitors. Pakistan Journal of Biological Sciences. 16(21). 1368–1372. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact